title: Effect of melatonin supplementation and cross-fostering on renal glutathione system and development of hypertension in spontaneously hypertensive rats.
abstract: Antenatal and postnatal environments are hypothesised to influence the development of hypertension. This study investigates the synergistic effect of cross-fostering and melatonin supplementation on the development of hypertension and renal glutathione system in spontaneously hypertensive rats (SHR). In one experiment, 1-day-old male SHR pups were fostered to either SHR (shr-SHR) or Wistar-Kyoto rats, (shr-WKY). In a concurrent experiment, SHR dams were given melatonin in drinking water (10 mg/kg body weight) from day 1 of pregnancy. Immediately following delivery, 1-day-old male pups were fostered either to SHR (Mel-shr-SHR) or WKY (Mel-shr-WKY) dams receiving melatonin supplementation until weaning on day 21. Upon weaning, melatonin supplementation was continued to these pups until the age of 16 weeks. Systolic blood pressures (SBP) were recorded at the age of 4, 6, 8, 12 and 16 weeks. Renal antioxidant activities were measured. Mean SBP of shr-WKY, Mel-shr-SHR and Mel-shr-WKY was significantly lower than that in shr-SHR until the age of 8 weeks. At 12 and 16 weeks of age, mean SBP of Mel-shr-WKY was lower than those in non-treated shr-SHR and shr-WKY pups but was not significantly different from that in Mel-shr-SHR. Renal glutathione peroxidase (GPx) and glutathione S-transferase (GST) activities were significantly higher in Mel-shr-SHR and Mel-shr-WKY at 16 weeks of age. It appears that combination of cross-fostering and melatonin supplementation exerts no synergistic effect on delaying the rise in blood pressure in SHR. The elevated GPx and GST activities are likely to be due to the effect of melatonin supplementation.
authors: Department of Physiology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150, Kubang Kerian, Kelantan, Malaysia, leesiewkeah@yahoo.co.uk.
authors: Lee
authors: L
authors: Siew-Keah
authors: Arunkumar
authors: A
authors: Sundaram
authors: K N S
authors: KN
authors: Sirajudeen
authors: Rahimah
authors: R
authors: Zakaria
authors: H J
authors: HJ
authors: Singh
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage*; D001794:Blood Pressure; D019587:Dietary Supplements; D004353:Drug Evaluation, Preclinical; D005260:Female; D005978:Glutathione / Q000378:metabolism*; D005979:Glutathione Peroxidase / Q000378:metabolism; D005980:Glutathione Reductase / Q000378:metabolism; D005982:Glutathione Transferase / Q000378:metabolism; D006973:Hypertension / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control*; D007668:Kidney / Q000378:metabolism*; D008297:Male; D008550:Melatonin / Q000008:administration & dosage*; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D014886:Weaning
chemical_list: D000975:Antioxidants; D005979:Glutathione Peroxidase; D005980:Glutathione Reductase; D005982:Glutathione Transferase; D005978:Glutathione; D008550:Melatonin
references: Ren Fail. 2008;30(10):1006-11
references: 19016153
references: J Physiol Biochem. 2010 Dec;66(4):321-7
references: 20680541
references: Clin Exp Pharmacol Physiol. 2011 Dec;38(12):854-9
references: 21973174
references: Hypertension. 2003 Feb;41(2):341-6
references: 12574105
references: Am J Physiol Regul Integr Comp Physiol. 2005 Oct;289(4):R913-35
references: 16183628
references: Kidney Int. 2004 Jan;65(1):219-27
references: 14675053
references: Indian J Physiol Pharmacol. 2008 Jul-Sep;52(3):283-7
references: 19552060
references: Circulation. 2007 Apr 24;115(16):2178-87
references: 17420349
references: Acta Physiol Scand. 1998 Jan;162(1):107-14
references: 9492908
references: Physiol Rev. 1999 Oct;79(4):1227-82
references: 10508234
references: Am J Physiol Renal Physiol. 2003 Mar;284(3):F447-54
references: 12441307
references: Am J Hypertens. 2007 Jan;20(1):62-9
references: 17198913
references: J Physiol Biochem. 2011 Jun;67(2):249-57
references: 21210316
references: Am J Physiol Heart Circ Physiol. 2002 Apr;282(4):H1255-61
references: 11893559
references: Hypertension. 2008 Apr;51(4):872-7
references: 18299484
references: Blood Purif. 1996;14(3):257-61
references: 8738540
references: Curr Opin Nephrol Hypertens. 2009 Mar;18(2):144-52
references: 19434052
references: J Pineal Res. 2001 Nov;31(4):370-7
references: 11703568
references: J Pineal Res. 1998 Mar;24(2):83-9
references: 9510432
references: Clin Exp Pharmacol Physiol Suppl. 1995 Dec;22(1):S215-7
references: 9072362
references: J Hypertens. 2009 Aug;27(8):1575-84
references: 19531963
references: Am J Physiol. 1987 Oct;253(4 Pt 2):H980-4
references: 3661746
references: Clin Exp Pharmacol Physiol. 2006 Jan-Feb;33(1-2):9-16
references: 16445693
references: Wien Klin Wochenschr. 1997 Jan 17;109(1):13-9
references: 9037743
references: Hypertension. 2000 Jul;36(1):142-6
references: 10904027
references: J Hypertens. 2008 Jul;26(7):1343-52
references: 18551009